PENK and Huntington disease: Altered levels of CSF PDYN and/or PENK-derived peptides have been reported in Alzheimer’s disease (AD), frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) and Huntington’s disease (HD) [8,9,10,11,12].